India’s first coronavirus disease (Covid-19) candidate vaccine, Covaxin, which is being developed by Bharat Biotech, is likely to be at least 60% effective. On Thursday evening, the company received approval from the Controller General of Medicines of India (DCGI) to conduct a phase 3 clinical trial to establish the efficacy …
Read More »India’s first Covid-19 vaccine will be at least 60% effective: Bharat Biotech – health
